Commonly used SNRIs may cause dependence and withdrawal when stopped

September 13, 2018, Journal of Psychotherapy and Psychosomatics
Credit: CC0 Public Domain

The difficulties that people have in discontinuing antidepressant medications has been in the news recently. An analysis published in the current issue of Psychotherapy and Psychosomatics on the effects of discontinuing commonly used antidepressant drugs like venlafaxine and duloxetine indicates that these drugs may cause dependence and withdrawal syndromes when they are stopped.

The Authors conducted a systematic review examining electronic databases including PubMed, the Cochrane Library, Web of Science, and MEDLINE from the inception of each database to June 2017. Sixty-one studies met the criteria for inclusion. There were 22 double-blind randomized controlled trials, 6 studies where patients were treated in an open fashion and then randomized to a double-blind controlled phase, 8 open trials, 1 prospective naturalistic study, 1 retrospective study, and 23 case reports. Results showed that symptoms occurred after discontinuation of any type of serotonin-noradrenalin reuptake inhibitor (SNRI). The prevalence of withdrawal symptoms varied across reports and appeared to be higher with venlafaxine. Symptoms typically ensued within a few days from discontinuation and lasted a few weeks, also with gradual tapering. Late onset and/or a longer persistence of disturbances occurred as well.

These findings highlight the need for clinicians to add SNRI to the list of drugs potentially inducing upon discontinuation, together with other types of psychotropic drugs. The leading author of the study, Giovanni A. Fava, MD (University of Bologna and University at Buffalo) comments: "this type of is widely used with the wrong assumption that they do not cause dependence and problems upon discontinuation. We should be more cautious in prescribing them and be aware of the problems that ensue when you stop them."

Explore further: Are antidepressants safe in patients with coronary heart disease?

More information: Giovanni A. Fava et al. Withdrawal Symptoms after Serotonin-Noradrenaline Reuptake Inhibitor Discontinuation: Systematic Review, Psychotherapy and Psychosomatics (2018). DOI: 10.1159/000491524

Related Stories

Are antidepressants safe in patients with coronary heart disease?

April 19, 2018
An investigation published in the current issue of Psychotherapy and Psychosomatics explores the cardiac events that may occur with the use of antidepressant drugs in coronary artery disease. The aim of this study was assessing ...

FDA approves non-opioid treatment for opioid withdrawal

May 18, 2018
(HealthDay)—Lucemyra (lofexidine hydrochloride) has been approved by the U.S. Food and Drug Administration to treat symptoms of opioid withdrawal.

New research on antidepressant addiction and withdrawal

June 6, 2018
A study of more than 1800 New Zealanders has found a significant number of people on antidepressants believe the drugs are addictive and more than half report experiencing withdrawal symptoms.

Paroxetine, an antidepressant drugs may provoke emotional disorders that persist after discontinuation

September 4, 2014
Three patients (two men and a woman) were referred to the Affective Disorders Program of the University of Bologna for paroxetine postwithdrawal symptoms. Patients were treated with paroxetine (from 20 to 60 mg/day) respectively ...

TNF inhibitors may not modify polyarticular JIA disease process

June 19, 2015
(HealthDay)—For children with polyarticular juvenile idiopathic arthritis (JIA), discontinuing medications is challenging, with high relapse rates, especially after discontinuation of tumor necrosis factor inhibitor (TNFi) ...

Depression and antidepressants are associated with an increased risk of VTE

July 24, 2018
In the first review of its kind, new research has found that depression and the use of antidepressants are each associated with an increased risk of venous thromboembolism (VTE). The study led by academics from the Musculoskeletal ...

Recommended for you

In depression the brain region for stress control is larger

September 20, 2018
Although depression is one of the leading psychiatric disorders in Germany, its cause remains unclear. A recent study at the Max Planck Institute for Human Cognitive and Brain Sciences (MPI CBS) in Leipzig, Germany, found ...

Quitting junk food produces similar withdrawal-type symptoms as drug addiction

September 20, 2018
If you plan to try and quit junk food, expect to suffer similar withdrawal-type symptoms—at least during the initial week—like addicts experience when they attempt to quit using drugs.

American girls read and write better than boys

September 20, 2018
As early as the fourth grade, girls perform better than boys on standardized tests in reading and writing, and as they get older that achievement gap widens even more, according to research published by the American Psychological ...

Mindfulness meditation: 10 minutes a day improves cognitive function

September 19, 2018
Practising mindfulness meditation for 10 minutes a day improves concentration and the ability to keep information active in one's mind, a function known as "working memory". The brain achieves this by becoming more efficient, ...

People can handle the truth (more than you think)

September 19, 2018
Most people value the moral principle of honesty. At the same time, they frequently avoid being honest with people in their everyday lives. Who hasn't told a fib or half-truth to get through an awkward social situation or ...

The 'real you' is a myth – we constantly create false memories to achieve the identity we want

September 19, 2018
We all want other people to "get us" and appreciate us for who we really are. In striving to achieve such relationships, we typically assume that there is a "real me". But how do we actually know who we are? It may seem simple ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.